MX2022005362A - Composiciones de trem para codones con-raros y usos relacionados. - Google Patents

Composiciones de trem para codones con-raros y usos relacionados.

Info

Publication number
MX2022005362A
MX2022005362A MX2022005362A MX2022005362A MX2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A
Authority
MX
Mexico
Prior art keywords
con
trem
compositions
rare codons
related uses
Prior art date
Application number
MX2022005362A
Other languages
English (en)
Spanish (es)
Inventor
David Arthur Berry
Theonie Anastassiadis
Christine Elizabeth Hajdin
Noubar Boghos Afeyan
Original Assignee
Flagship Pioneering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Inc filed Critical Flagship Pioneering Inc
Publication of MX2022005362A publication Critical patent/MX2022005362A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
MX2022005362A 2019-11-04 2020-11-04 Composiciones de trem para codones con-raros y usos relacionados. MX2022005362A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962930361P 2019-11-04 2019-11-04
PCT/US2020/058948 WO2021092064A1 (en) 2019-11-04 2020-11-04 Trem compositions for con-rare codons and related uses

Publications (1)

Publication Number Publication Date
MX2022005362A true MX2022005362A (es) 2022-09-23

Family

ID=73654885

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005362A MX2022005362A (es) 2019-11-04 2020-11-04 Composiciones de trem para codones con-raros y usos relacionados.

Country Status (9)

Country Link
US (1) US20220364092A1 (cg-RX-API-DMAC10.html)
EP (1) EP4055163A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023500116A (cg-RX-API-DMAC10.html)
KR (1) KR20220128611A (cg-RX-API-DMAC10.html)
CN (1) CN115003810A (cg-RX-API-DMAC10.html)
AU (1) AU2020379762A1 (cg-RX-API-DMAC10.html)
CA (1) CA3160097A1 (cg-RX-API-DMAC10.html)
MX (1) MX2022005362A (cg-RX-API-DMAC10.html)
WO (1) WO2021092064A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004587A (es) 2017-11-02 2021-04-12 Univ Iowa Res Found Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt.
JP7712270B2 (ja) 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
EP4158032A2 (en) * 2020-05-29 2023-04-05 Flagship Pioneering Innovations VI, LLC Trem compositions and methods relating thereto

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20080318884A1 (en) * 2005-03-25 2008-12-25 The Uab Research Foundation Methods for Altering Gene Expression and Methods of Treatment Utilizing Same
GB0600948D0 (en) * 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
WO2010141851A1 (en) * 2009-06-05 2010-12-09 Salk Institute For Biological Studies Improving unnatural amino acid incorporation in eukaryotic cells
US9676810B2 (en) * 2010-07-08 2017-06-13 The Brigham And Women's Hospital, Inc. Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
KR102485491B1 (ko) * 2012-10-02 2023-01-04 벡션 테라퓨틱스 엘엘씨 면역 조절성 미니세포 및 사용 방법
BR112016011195A2 (pt) 2013-11-18 2017-09-19 Rubius Therapeutics Inc Células eritroides enucleadas e seus métodos de fabricação, composição farmacêutica e seu uso, uso de uma população de células eritroides, biorreator, mistura de células e dispositivo médico
CN106456744A (zh) 2014-04-01 2017-02-22 鲁比厄斯治疗法股份有限公司 用于免疫调节的方法和组合物
WO2016183482A1 (en) 2015-05-13 2016-11-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
CN108697733A (zh) 2016-01-11 2018-10-23 鲁比厄斯治疗法股份有限公司 与癌症适应症的多模式治疗性细胞体系有关的组合物和方法
MX2019000205A (es) 2016-07-07 2019-09-23 Rubius Therapeutics Inc Composiciones y metodos relacionados con sistemas celulares terapeuticos que expresan arn exogeno.
BR112019011138A2 (pt) 2016-12-02 2019-10-01 Rubius Therapeutics, Inc. composições e métodos relacionados com sistemas celulares para penetração em tumores sólidos
CN110520522A (zh) 2017-02-17 2019-11-29 鲁比厄斯治疗法股份有限公司 功能化红系细胞
US11576872B2 (en) 2017-05-08 2023-02-14 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
EA202190736A1 (ru) * 2018-09-26 2021-09-16 Кейс Вестерн Ризерв Юниверсити Способы и композиции для увеличения экспрессии белка и/или лечения расстройства, связанного с гаплонедостаточностью
IL284878B2 (en) * 2019-01-18 2026-04-01 Flagship Pioneering Inc TREM preparations and their uses
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用

Also Published As

Publication number Publication date
KR20220128611A (ko) 2022-09-21
AU2020379762A1 (en) 2022-05-26
CA3160097A1 (en) 2021-05-14
EP4055163A1 (en) 2022-09-14
CN115003810A (zh) 2022-09-02
US20220364092A1 (en) 2022-11-17
JP2023500116A (ja) 2023-01-04
WO2021092064A1 (en) 2021-05-14

Similar Documents

Publication Publication Date Title
WO2020160193A3 (en) Compounds and uses thereof
WO2020243415A3 (en) Tead inhibitors and uses thereof
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
WO2020039321A8 (en) Anti-gdf15 antibodies, compositions and methods of use
WO2021127283A3 (en) Irak degraders and uses thereof
AU2020317609A8 (en) Novel heteroaryl-triazole compounds as pesticides
WO2020097537A3 (en) Fused ring compounds
PH12022551522A1 (en) Smarca degraders and uses thereof
PH12019501812A1 (en) Compositions and methods for the treatment of hemoglobinopathies
MX2022012955A (es) Composiciones de trem y usos de las mismas.
EP4306653A3 (en) Multiplexed optimized mismatch amplification (moma)-target number
PH12022551228A1 (en) Trem2 antibodies and uses thereof
ZA202309446B (en) Rapamycin analogs and uses thereof
EP4279071A3 (en) Novel cannabinoid formulations
GB2568181A (en) Wheat
MX2021006515A (es) Composiciones de methylobacterium para mejorar el rendimiento del maíz.
MX2021003180A (es) Métodos y kits para preparar sangre entera con inactivación de patógenos.
AU2018279184A1 (en) Anti-TrkB antibodies
MX2019013419A (es) Compuestos plaguicidas biciclicos.
MY188420A (en) Crystalline forms of (s)-afoxolaner
MX2024004568A (es) Composiciones de trem y metodos de uso.
AU2019207521A8 (en) High amylose wheat - IV
MX2022001641A (es) Composiciones fermentadas y procedimientos de preparacion de las mismas.
MX2022006776A (es) Composiciones farmaceuticas oftalmicas.
WO2020186090A3 (en) Activatable specific binding member complexes, and methods of making and using same